Legal & General Group
ACLX

Legal & General Group’s Arcellx ACLX Stock Holding History

Legal & General Group’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Sell
21,888
-7,677
-26% -$678K ﹤0.01% 1818
2025
Q4 		$1.93M Buy
29,565
+572
+2% +$45.6K ﹤0.01% 1980
2025
Q3 		$2.38M Sell
28,993
-5,819
-17% -$419K ﹤0.01% 1907
2025
Q2 		$2.29M Sell
34,812
-6,795
-16% -$423K ﹤0.01% 1917
2025
Q1 		$2.73M Sell
41,607
-1,426
-3% -$96.6K ﹤0.01% 1810
2024
Q4 		$3.3M Buy
43,033
+2,331
+6% +$201K ﹤0.01% 1765
2024
Q3 		$3.4M Buy
40,702
+5,297
+15% +$353K ﹤0.01% 1758
2024
Q2 		$1.95M Buy
35,405
+6,061
+21% +$329K ﹤0.01% 1953
2024
Q1 		$2.04M Sell
29,344
-418
-1% -$26.5K ﹤0.01% 1934
2023
Q4 		$1.65M Sell
29,762
-105
-0.4% -$4.74K ﹤0.01% 2033
2023
Q3 		$1.07M Buy
29,867
+5,230
+21% +$180K ﹤0.01% 2164
2023
Q2 		$779K Buy
24,637
+17,484
+244% +$668K ﹤0.01% 2306
2023
Q1 		$220K Buy
7,153
+489
+7% +$14.8K ﹤0.01% 2558
2022
Q4 		$206K Buy
6,664
+3,905
+142% +$89.6K ﹤0.01% 2597
2022
Q3 		$52K Buy
2,759
+1,867
+209% +$35.7K ﹤0.01% 2961
2022
Q2 		$16K Buy
892
+49
+6% +$632 ﹤0.01% 3299
2022
Q1 		$12K Buy
+843
New +$14.1K ﹤0.01% 3353

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Legal & General Group's ACLX Position: Q1 2026 in Review

Legal & General Group reduced its Arcellx (ACLX) stake by 26% in Q1 2026, selling an estimated $678K and leaving 21,888 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Legal & General Group first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.4M in Q3 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Legal & General Group held 21,888 shares of Arcellx worth $2.51M as of Q1 2026.
  • Legal & General Group sold 7,677 Arcellx shares in Q1 2026, an estimated $678K.
  • Arcellx made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1818 holding.
  • Legal & General Group first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • Legal & General Group's Arcellx position peaked at $3.4M in Q3 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.